SCHEMBL19009548

SCHEMBL19009548

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccc(-c6ncccn6)cc5)cc4)nc(-c4cccc5ccccc45)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.50
SMN1; SMN2 Q16637 7/20 0.50
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 6/20 0.50
HPGD P15428 6/20 0.50
HSD17B10 Q99714 5/20 0.50
MAPK1 P28482 3/20 0.50
TP53 P04637 3/20 0.50
TSHR P16473 3/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
ATM Q13315 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
NPC1 O15118 4/20 0.46
RAB9A P51151 5/20 0.43
LMNA P02545 3/20 0.43
TNF P01375 1/20 0.42
RECQL P46063 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21982137 0.95 MAPT (0.47) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL17944675 0.95 KDM4E (0.49) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL15274132 0.92 MAPT (0.57) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL22096217 0.92 MAPT (0.57) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL2257581 0.92 MAPT (0.57) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23730320 0.92 MAPT (0.57) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL6370565 0.92 MAPT (0.57) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL15274131 0.92 MAPT (0.57) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25668539 0.90 MAPT (0.56) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25668543 0.90 MAPT (0.56) MAPTSMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MAPT 735/4885SMN1; SMN2 4133/4885KDM4E 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.